Sufficient time has already elapsed and the number of cases has been amply large to permit a retrospective analysis of the salvarsan treatment of syphilis and an estimation of its true and relative worth. Despite the fact that it fails, from both a clinical and laboratory point of view, to effect a permanent cure here and there, it is safe to assume at present that it has clearly demonstrated itself to be the sovereign remedy for the succesful treatment of the various stages of syphilis and has definitely acquired an indispensable place in this important field of therapy. It is no longer necessary to determine whether it is a useful or a useless remedy, whether its results are efficacious or futile, its effects good or bad, or whether it should or should not be administered in all well-defined cases of active syphilis. There is scarcely a person of even moderate
HEIDINGSFELD ML. CLINICAL AND LABORATORY SALVARSAN RELAPSES AND THEIR REMEDY: A SEROLOGIC STUDY OF SIX HUNDRED FIFTY-ONE CASES COVERING NINE HUNDRED FIFTY-TWO INTRAVENOUS ADMINISTRATIONS AND THREE THOUSAND THREE HUNDRED FOUR WASSERMANN EXAMINATIONS. JAMA. 1913;61(18):1598–1601. doi:10.1001/jama.1913.04350190016005
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: